サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：感染性呼吸器疾患診断の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
市場調査レポート
商品コード
1342965

感染性呼吸器疾患診断の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測

Global Infectious Respiratory Disease Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 210 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
感染性呼吸器疾患診断の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
出版日: 2023年08月01日
発行: Value Market Research
ページ情報: 英文 210 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

呼吸器感染症診断市場の世界需要は、2022年の659億2,000万米ドルから2030年には854億1,000万米ドル近くの市場規模に達すると推定され、調査期間2023～2030年のCAGRは2.92%です。

呼吸器感染症は、ウイルス、細菌、その他の病原微生物によって引き起こされます。呼吸器系に感染する可能性のある微生物は、くしゃみ、咳、会話、笑いの際に唾液や粘液（呼吸器分泌物とも呼ばれる）を介して急速に拡散します。一般的な感染性呼吸器疾患には、インフルエンザ、麻疹、結核、百日咳、風疹などがあります。

市場力学：

感染性呼吸器疾患診断市場は、呼吸器疾患の有病率の増加、高度な分子生物学的手法の利用の増加、高齢者人口の増加、感染症のリスクを低減するための政府や知名度の低い組織による取り組みによって牽引されています。さらに、自己検査製品やポイント・オブ・ケア製品の利用が増加していることも、市場の成長を促進すると思われます。感染症診断のための診断や消耗品に対する需要の増加に対応するための革新的な技術の開拓が増加していることも、呼吸器疾患診断市場の成長を促進する要因です。結核や肺炎などの肺疾患や、慢性気管支炎、肺気腫、喘息などの慢性閉塞性肺疾患患者の急増は、市場の成長を促進します。さらに、下気道感染症を検出するための診断テストやツールに対する需要の高まりは、市場の成長を増大させると思われます。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは感染性呼吸器疾患診断の世界市場における各セグメントを包括的に評価することもできます。感染性呼吸器疾患診断産業の成長と動向は、本調査に全体的なアプローチを提供します。

地域分析：

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカにおける感染性呼吸器疾患診断市場の現在と将来の需要を強調する地域展望をカバーします。さらに、本レポートは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 感染性呼吸器疾患診断- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

5 COVID-19発生の影響分析

第6章 感染性呼吸器疾患診断の世界市場分析：製品タイプ別

  • 概要：製品タイプ別
  • 実績データと予測データ
  • 分析：製品タイプ別
  • 機器（画像検査機器、呼吸器測定機器、その他機器）
  • 消耗品
  • サービス

第7章 感染性呼吸器疾患診断の世界市場分析：サンプルタイプ別

  • サンプルタイプ別概要
  • 実績データと予測データ
  • サンプルタイプ別分析
  • 唾液
  • 鼻咽頭スワブ（NPS）
  • 前鼻腔領域
  • 血液
  • その他

第8章 感染性呼吸器疾患診断の世界市場分析：用途別

  • 概要：用途別
  • 実績データと予測データ
  • 分析：用途別
  • COVID-19
  • インフルエンザ
  • RSV（呼吸器合胞体ウイルス）
  • 結核
  • 溶連菌検査
  • その他の呼吸器疾患検査

第9章 感染性呼吸器疾患診断の世界市場分析：技術別

  • 技術別概要
  • 実績データと予測データ
  • 技術別分析
  • 免疫測定法
  • 分子診断
  • 微生物学
  • その他の技術

第10章 感染性呼吸器疾患診断の世界市場分析：最終用途別

  • 最終用途別概要
  • 実績データと予測データ
  • 最終用途別分析
  • 病院
  • 診断研究所
  • 医院
  • その他のエンドユーザー

第11章 感染性呼吸器疾患診断の世界市場分析：地域別

  • 上位企業シェア分析
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第12章 感染性呼吸器疾患診断企業の競合情勢

  • 感染性呼吸器疾患診断市場競争
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品上市
  • その他の開発

第13章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Abbott
  • Thermo Fisher Scientific Inc.
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd.
  • bioMerieux SA
  • BD
  • Quidel Corporation
  • QIAGEN
  • Danaher
  • Siemens Healthcare GmbH
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product Type (USD MN)
  • Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments) Market Sales by Geography (USD MN)
  • Consumables Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Sample Type (USD MN)
  • Saliva Market Sales by Geography (USD MN)
  • Nasopharyngeal Swabs (NPS) Market Sales by Geography (USD MN)
  • Anterior Nasal Region Market Sales by Geography (USD MN)
  • Blood Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • COVID-19 Market Sales by Geography (USD MN)
  • Influenza Market Sales by Geography (USD MN)
  • RSV (Respiratory Syncytial Virus) Market Sales by Geography (USD MN)
  • Tuberculosis Market Sales by Geography (USD MN)
  • Streptococcus Testing Market Sales by Geography (USD MN)
  • Other Respiratory Disease Testing Market Sales by Geography (USD MN)
  • Analysis by Technology (USD MN)
  • Immunoassay Market Sales by Geography (USD MN)
  • Molecular Diagnostics Market Sales by Geography (USD MN)
  • Microbiology Market Sales by Geography (USD MN)
  • Other technologies Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Physician Offices Market Sales by Geography (USD MN)
  • Other End Users Market Sales by Geography (USD MN)
  • Global Infectious Respiratory Disease Diagnostics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Infectious Respiratory Disease Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Infectious Respiratory Disease Diagnostics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Sample Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments) Market Sales by Geography (USD MN)
  • Consumables Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Sample Type (USD MN)
  • Saliva Market Sales by Geography (USD MN)
  • Nasopharyngeal Swabs (NPS) Market Sales by Geography (USD MN)
  • Anterior Nasal Region Market Sales by Geography (USD MN)
  • Blood Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • COVID-19 Market Sales by Geography (USD MN)
  • Influenza Market Sales by Geography (USD MN)
  • RSV (Respiratory Syncytial Virus) Market Sales by Geography (USD MN)
  • Tuberculosis Market Sales by Geography (USD MN)
  • Streptococcus Testing Market Sales by Geography (USD MN)
  • Other Respiratory Disease Testing Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Immunoassay Market Sales by Geography (USD MN)
  • Molecular Diagnostics Market Sales by Geography (USD MN)
  • Microbiology Market Sales by Geography (USD MN)
  • Other technologies Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Physician Offices Market Sales by Geography (USD MN)
  • Other End Users Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219207

The global demand for Infectious Respiratory Disease Diagnostics Market is presumed to reach the market size of nearly USD 85.41 BN by 2030 from USD 65.92 BN in 2022 with a CAGR of 2.92% under the study period 2023 - 2030.

Respiratory infectious diseases are caused by viruses, bacteria, or other pathogenic microbes. Microbes that can infect the respiratory system are rapidly spread through saliva & mucus (also referred to as respiratory secretions) when a person sneezes, coughs, talks or laughs. Some common infectious respiratory diseases are influenza, measles, tuberculosis, pertussis, rubella, etc.

MARKET DYNAMICS:

The market for infectious respiratory disease diagnostics is driven by an increasing prevalence of respiratory diseases, increasing use of advanced molecular biology techniques, a rising elderly population, and initiatives taken by the government and low-profile organizations to decrease the risk of infectious diseases. Moreover, increasing usage of self-testing products & point of care products will flourish the market growth. The rise in the development of innovative techniques for meeting the increasing demand for diagnostics & consumables for the diagnosis of infectious diseases is another factor driving the growth of the respiratory disease diagnostics market. The surge in cases of lung diseases, including tuberculosis & pneumonia and other chronic obstructive pulmonary disorders like chronic bronchitis, emphysema, and asthma, will foster market growth. Furthermore, rising demand for diagnostic tests & tools to detect lower respiratory infectious disease will augment the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of infectious respiratory disease diagnostics. The growth and trends of infectious respiratory disease diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the infectious respiratory disease diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments)
  • Consumables
  • Services

By Sample Type

  • Saliva
  • Nasopharyngeal Swabs (NPS)
  • Anterior Nasal Region
  • Blood
  • Others

By Application

  • COVID-19
  • Influenza
  • RSV (Respiratory Syncytial Virus)
  • Tuberculosis
  • Streptococcus Testing
  • Other Respiratory Disease Testing

By Technology

  • Immunoassay
  • Molecular Diagnostics
  • Microbiology
  • Other Technologies

By End-Use

  • Hospitals
  • Diagnostic Laboratories
  • Physician Offices
  • Other End Users

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Infectious Respiratory Disease Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the infectious respiratory disease diagnostics market include Abbott, Thermo Fisher Scientific Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., bioMerieux SA, BD, Quidel Corporation, QIAGEN, Danaher, Siemens Healthcare GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Sample Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Technology
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1 Overview by Product Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Type
  • 6.4 Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments) Historic and Forecast Sales by Regions
  • 6.5 Consumables Historic and Forecast Sales by Regions
  • 6.6 Services Historic and Forecast Sales by Regions

7 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE

  • 7.1 Overview by Sample Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Sample Type
  • 7.4 Saliva Historic and Forecast Sales by Regions
  • 7.5 Nasopharyngeal Swabs (NPS) Historic and Forecast Sales by Regions
  • 7.6 Anterior Nasal Region Historic and Forecast Sales by Regions
  • 7.7 Blood Historic and Forecast Sales by Regions
  • 7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 COVID-19 Historic and Forecast Sales by Regions
  • 8.5 Influenza Historic and Forecast Sales by Regions
  • 8.6 RSV (Respiratory Syncytial Virus) Historic and Forecast Sales by Regions
  • 8.7 Tuberculosis Historic and Forecast Sales by Regions
  • 8.8 Streptococcus Testing Historic and Forecast Sales by Regions
  • 8.9 Other Respiratory Disease Testing Historic and Forecast Sales by Regions

9 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

  • 9.1 Overview by Technology
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Technology
  • 9.4 Immunoassay Historic and Forecast Sales by Regions
  • 9.5 Molecular Diagnostics Historic and Forecast Sales by Regions
  • 9.6 Microbiology Historic and Forecast Sales by Regions
  • 9.7 Other technologies Historic and Forecast Sales by Regions

10 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY END-USE

  • 10.1 Overview by End-use
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by End-use
  • 10.4 Hospitals Historic and Forecast Sales by Regions
  • 10.5 Diagnostic Laboratories Historic and Forecast Sales by Regions
  • 10.6 Physician Offices Historic and Forecast Sales by Regions
  • 10.7 Other End Users Historic and Forecast Sales by Regions

11 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS COMPANIES

  • 12.1. Infectious Respiratory Disease Diagnostics Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Abbott
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Thermo Fisher Scientific Inc.
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Koninklijke Philips N.V.
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. F. Hoffmann-La Roche Ltd.
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. bioMerieux SA
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. BD
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Quidel Corporation
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. QIAGEN
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Danaher
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. Siemens Healthcare GmbH
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies